SQUAWK/NEWS
Account
Account
Menu
Live NewsCategoriesequity

Jasper Therapeutics, Inc. (JSPR) News

Track canonical SquawkNews coverage tagged to JSPR, Jasper Therapeutics, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 6 indexed stories across 3 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol JSPR Asset equity Sector Markets 90 days 6 Last 0.9004 Updated Aug 12, 2026, 10:47 AM UTC Open live news feed
M Piper Initiates JSPR, LPTH, MRCY, UMAC Overweight Piper initiates JSPR, LPTH, MRCY, UMAC at overweight, while JPM starts FLUT at neutral and Chardan starts QMLS at buy EQUITY | Aug 12, 2026, 10:47 AM UTC M JSPR Initiated Overweight at Piper JSPR initiated with Overweight rating at Piper with $2 price target EQUITY | Aug 12, 2026, 09:44 AM UTC H Deal Dispatch: Uber Buys Delivery Hero For $14.8 Billion, Eli Lilly Acquires AtaiBeckley, Lulu’s Fashion Considers Strategic Alternatives New On The Block Lulu’s Fashion Lounge Holdings (NASDAQ: LVLU ) retained Solomon Partners as its financial advisor and Willkie Farr & Gallagher LLP as its legal advisor as the company evaluates strategic alternatives to EARNINGS | Jul 17, 2026, 05:18 PM UTC H Why Callan JMB Shares Are Trading Higher By Around 64%; Here Are 20 Stocks Moving Premarket Shares of Callan JMB Inc (NASDAQ: CJMB ) rose sharply in pre-market trading following the announcement that Callan JMB signed a strategic partnership with Alabama State University to build an integrated pharmaceutical ma MACRO | Jul 17, 2026, 08:48 AM UTC L JSPR - resumes trading after halt, +59% in AHs JSPR - resumes trading after halt, +59% in AHs EQUITY | Jul 16, 2026, 09:48 PM UTC H JSPR - PR: Jasper Therapeutics Announces Merger with Kira Pharmaceuticals -Combined company positioned to advance portfolio of biologic agen JSPR - PR: Jasper Therapeutics Announces Merger with Kira Pharmaceuticals -Combined company positioned to advance portfolio of biologic agents designed to improve outcomes in patients with numerous immunologically-driven MNA | Jul 16, 2026, 09:20 PM UTC